imiquimod has been researched along with sq-23377 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambach, A; Bonnekoh, B; Gollnick, H; Nguyen, M; Schön, MP | 1 |
1 other study(ies) available for imiquimod and sq-23377
Article | Year |
---|---|
Imiquimod, a Toll-like receptor-7 agonist, induces perforin in cytotoxic T lymphocytes in vitro.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antineoplastic Agents; Antiviral Agents; Cells, Cultured; Cytoplasmic Granules; Dermatitis, Atopic; Flow Cytometry; Humans; Imiquimod; Ionomycin; Membrane Glycoproteins; Perforin; Pore Forming Cytotoxic Proteins; Receptors, Cell Surface; T-Lymphocytes, Cytotoxic; Tetradecanoylphorbol Acetate; Toll-Like Receptor 7; Toll-Like Receptors | 2004 |